ATTN LogoMenu
4JAZZTier 5
Articles

Jazz Pharmaceuticals plc 4

0001754371-26-000004

View on SEC EDGAR

Non-employee director Jennifer E. Cook received an award of 1,605 RSUs of Jazz Pharmaceuticals plc on August 5, 2026.

On August 5, 2026, Jennifer E. Cook, a non-employee director of Jazz Pharmaceuticals plc, received a grant of 1,605 restricted stock units (RSUs) representing ordinary shares under the company’s 2007 Amended and Restated Non-Employee Directors Stock Award Plan. The RSUs were awarded at no cash cost to her and will vest in full on July 23, 2027, subject to her continued service and other conditions. Following this equity award, her direct ownership increased to 12,442 ordinary shares (including the newly granted RSUs), reflecting routine director compensation rather than an open-market purchase or sale.

Filing Facts

CIK
1232524
Ticker
JAZZ
Form
4
Source Type
fda
Accession
0001754371-26-000004
Alert Tier
5
Jazz Pharmaceuticals plc 4 | ATTN